Top Markets
#1 QuantixAI QuantixAI +31.15%
#2 Prom Prom +29.37%
#3 MowCat MowCat +27.03%
#4 Tutorial Tutorial +25.45%
#5 Pons Pons +23.80%
#6 UnifAI Network UnifAI Network +23.49%
#7 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +19.80%
#8 Derive Derive +19.11%
#9 Versatize Coin Versatize Coin +16.66%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.19%
Coin of the day
QuantixAI QuantixAI
설정
언어
한국어
통화
USD
테마
Bioceltix S.a. Bioceltix S.a.

Bioceltix S.a.

BCX
주식 순위 #20646
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals... Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The company’s products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
주가
$22.66
시가총액
$125.37M
변동 (1일)
0.63%
변동 (1년)
-21.46%
국가
PL
거래 Bioceltix S.a. (BCX)

카테고리

Healthcare
Bioceltix S.a. (BCX)의 P/S 비율
2026 기준 P/S 비율 TTM: 0
Bioceltix S.a.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0입니다. 2026년 말 기준 P/S 비율은 0였습니다.
Bioceltix S.a.의 P/S 비율 기록 (2026 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH